These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15629540)

  • 21. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension.
    Gentile MT; Poulet R; Di Pardo A; Cifelli G; Maffei A; Vecchione C; Passarelli F; Landolfi A; Carullo P; Lembo G
    Neurobiol Aging; 2009 Feb; 30(2):222-8. PubMed ID: 17673335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice.
    Davis J; Xu F; Miao J; Previti ML; Romanov G; Ziegler K; Van Nostrand WE
    Neurobiol Aging; 2006 Jul; 27(7):946-54. PubMed ID: 16105708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.
    Ito S; Ohtsuki S; Terasaki T
    Neurosci Res; 2006 Nov; 56(3):246-52. PubMed ID: 16926058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel monoclonal antibody specific for the amino-truncated beta-amyloid Abeta5-40/42 produced from caspase-cleaved amyloid precursor protein.
    Murayama KS; Kametani F; Tabira T; Araki W
    J Neurosci Methods; 2007 Apr; 161(2):244-9. PubMed ID: 17207535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer.
    Nakaoke R; Ryerse JS; Niwa M; Banks WA
    Exp Neurol; 2005 May; 193(1):101-9. PubMed ID: 15817268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
    Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular delivery of a single chain antibody gene reduces brain Abeta burden in a mouse model of Alzheimer's disease.
    Wang YJ; Pollard A; Zhong JH; Dong XY; Wu XB; Zhou HD; Zhou XF
    Neurobiol Aging; 2009 Mar; 30(3):364-76. PubMed ID: 17686552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGFalpha and the blood-brain barrier: accumulation in cerebral vasculature.
    Pan W; Vallance K; Kastin AJ
    Exp Neurol; 1999 Dec; 160(2):454-9. PubMed ID: 10619562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease.
    Banks WA; Terrell B; Farr SA; Robinson SM; Nonaka N; Morley JE
    Peptides; 2002 Dec; 23(12):2223-6. PubMed ID: 12535702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-beta: a vascular sealant that protects against hemorrhage?
    Atwood CS; Bishop GM; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):356. PubMed ID: 12391596
    [No Abstract]   [Full Text] [Related]  

  • 36. Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease.
    Banks WA; Robinson SM; Verma S; Morley JE
    Neuroscience; 2003; 121(2):487-92. PubMed ID: 14522007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody to beta-amyloid protein increases acetylcholine in the hippocampus of 12 month SAMP8 male mice.
    Farr SA; Banks WA; Uezu K; Sano A; Gaskin FS; Morley JE
    Life Sci; 2003 Jun; 73(5):555-62. PubMed ID: 12770611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42.
    Vojdani A; Vojdani E
    Int J Alzheimers Dis; 2018; 2018():1672568. PubMed ID: 30034864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain reactive antibodies and the blood-brain barrier: observations in aging rodents and the effects of peripheral kainic acid.
    Kulmala HK; Boja JW; Albrecht JW; Hutton JT
    Exp Aging Res; 1987; 13(1-2):67-72. PubMed ID: 3678354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional variations in the transport of interleukin-1alpha across the blood-brain barrier in ICR and aging SAMP8 mice.
    Moinuddin A; Morley JE; Banks WA
    Neuroimmunomodulation; 2000; 8(4):165-70. PubMed ID: 11251390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.